Dosidal · Belgium
Hexabrix 320 mg I/ml
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:115245-01 (version 1) |
| Level | presentation |
| Pack code | be-cnk (Belgian national): 0808469 |
| Identifiers | be-cti-extended: 115245-01 be-cnk: 0808469 be-authorisation: BE115245 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: REVOKED ampp_status: REVOKED commercialised_now: False lifecycle: history period_from: 1980-01-01 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM115245-00 atc: V08AB03 authorisation_number: BE115245 cti_extended: 115245-01 form: Solution for injection holder: Guerbet medicine_type: ALLOPATHIC name: Hexabrix 320 mg I/ml pack: 100 ml parallel_circuit: 0 parallel_import: False substances: strength: 393.0000 mg/mL substance: Ioxaglate Meglumine; strength: 196.5000 mg/mL substance: Sodium Ioxaglate state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | cnk_public: 0808469 fmd_in_scope: False note: no FMD product code in SAM for this pack: the maker's GTIN is not published state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53zuCgz2GFEdmH0vNZF0JhhpD3vRDzk3ldSIbnifZBthtWK9qd733hK19GLa565Ji-QSuuZsaat3Dq-apx6Ae23wVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |